| Literature DB >> 35404832 |
Gavin R McCormack1,2,3,4, Jennie Petersen1,5, Dalia Ghoneim1, Anita Blackstaffe1, Calli Naish1,6, Patricia K Doyle-Baker3,4,7.
Abstract
BACKGROUND: Health-promotion interventions incorporating wearable technology or eHealth apps can encourage participants to self-monitor and modify their physical activity and sedentary behavior. In 2020, a Calgary (Alberta, Canada) recreational facility developed and implemented a health-promotion intervention (Vivo Play Scientist program) that provided a commercially available wearable activity tracker and a customized eHealth dashboard to participants free of cost.Entities:
Keywords: COVID-19; activity tracker; digital health; eHealth; exercise; fitness; health promotion; intervention; mHealth; mixed methods study; physical activity; sensor; technology; wearable; wearable technology
Year: 2022 PMID: 35404832 PMCID: PMC9115656 DOI: 10.2196/37348
Source DB: PubMed Journal: JMIR Form Res ISSN: 2561-326X
Figure 1Screenshot of the dashboard information available to Vivo Play Scientist program participants.
Figure 2Flow diagram of participant recruitment.
Baseline characteristics of intervention participants (N=87).
| Characteristic | Value | ||
|
| |||
|
| Male | 22 (25) | |
|
| Female | 65 (75) | |
|
| |||
|
| No university | 25 (29) | |
|
| Completed university | 62 (71) | |
|
| |||
|
| <80,000 | 22 (25) | |
|
| 80,000-119,999 | 33 (38) | |
|
| >119,999 | 23 (26) | |
|
| Don’t know/refuse to answer | 9 (10) | |
|
| |||
|
| Chinese | 32 (37) | |
|
| Caucasian | 23 (26) | |
|
| South Asian | 9 (10) | |
|
| Japanese | 5 (6) | |
|
| Southeast Asian | 3 (3) | |
|
| Other (eg, African, West Asian, Latin American, Indigenous, other) | 15 (17) | |
|
| |||
|
| Yes | 17 (20) | |
|
| No | 70 (80) | |
|
| |||
|
| Full time/part time | 64 (74) | |
|
| Other | 23 (26) | |
|
| |||
|
| Married/common law | 73 (84) | |
|
| Other | 14 (16) | |
|
| |||
|
| One adult only | 22 (25) | |
|
| Multiple adults only | 8 (9) | |
|
| One adult and child(ren) | 29 (33) | |
|
| Multiple adults and child(ren) | 28 (32) | |
| Age (years), mean (SD) | 39.8 (7.4) | ||
| Number of children, mean (SD) | 1.8 (1.1) | ||
aCAD $1=US $0.79.
Differences in self-reported physical activity and sedentary behavior at baseline (T0), 4 weeks (T1), and 8 weeks (T2) (N=87).
| Variable | Friedman test | T0, mean (SD) | T1, mean (SD) | T2, mean (SD) | |||
|
|
|
|
| T0 vs T1 | T0 vs T2 | ||
| Walking (min/week) | 9.394 | .009 | 180.34 (262.92) | 167.82 (155.48) | 253.79 (315.23) | .21 | .005 |
| MPAb (min/week) | 1.465 | .48 | 61.03 (86.76) | 63.79 (97.55) | 90.91 (158.56) | — | — |
| VPAc (min/week) | 0.469 | .79 | 62.76 (73.62) | 65.06 (82.41) | 74.25 (111.74) | — | — |
| Total PAd (METe min/week) | 2.983 | .23 | 1334.45 (1341.31) | 1324.37 (1221.67) | 1861.88 (2150.45) | — | — |
| Days of MVPAf≥30 min/day | 1.979 | .37 | 2.74 (1.98) | 3.16 (2.04) | 3.16 (2.00) | — | — |
| Sitting (min/day) | 14.268 | <.001 | 334.26 (201.64) | 260.46 (185.15) | 267.13 (190.07) | <.001 | <.001 |
| Screen time (min/day) | 5.244 | .07 | 175.86 (156.16) | 144.71 (134.14) | 145.40 (148.01) | — | — |
aWilcoxon signed-rank tests with P<.025 (planned comparisons T0 vs T1 and T0 vs T1) considered statistically significant. The Wilcoxon signed-rank test was only undertaken when the Friedman test was significant (P<.05).
bMPA: moderate-intensity physical activity.
cVPA: vigorous-intensity physical activity.
dPA: physical activity.
eMET: metabolic equivalent.
fMVPA: moderate-to-vigorous physical activity.
Differences in self-reported physical activity and sedentary behavior at baseline (T0), 4 weeks (T1), and 8 weeks (T2) according to history of activity tracker use (N=87).
| Variable | Friedman test | T0, mean (SD) | T1, mean (SD) | T2, mean (SD) | |||||||||||
|
|
|
|
| T0 vs T1 | T0 vs T2 | ||||||||||
|
| |||||||||||||||
|
| Walking (min/week) | 6.993 | .03 | 186.00 (238.22) | 168.50 (145.51) | 208.75 (185.72) | .38 | .07 | |||||||
|
| MPAb (min/week) | 1.476 | .48 | 62.5 (95.48) | 67.25 (92.68) | 76.50 (110.70) | — | — | |||||||
|
| VPAc (min/week) | 1.317 | .52 | 69.00 (77.65) | 72.5 (80.69) | 78.5 (78.92) | — | — | |||||||
|
| Total PAd (METe min/week) | 4.088 | .13 | 1398.80 (1269.45) | 1384.05 (1165.64) | 1614.88 (1369.12) | — | — | |||||||
|
| Days of MVPAf≥30 min/day | 0.774 | .68 | 2.70 (1.94) | 3.25 (1.86) | 3.37 (2.03) | — | — | |||||||
|
| Sitting (min/day) | 11.036 | .004 | 365.50 (203.61) | 285.00 (182.01) | 292.50 (192.80) | .002 | .04 | |||||||
|
| Screen time (min/day) | 3.263 | .20 | 195.25 (173.31) | 154.25 (108.96) | 162.25 (168.96) | — | — | |||||||
|
| |||||||||||||||
|
| Walking (min/week) | 3.012 | .22 | 175.53 (284.74) | 167.23 (165.03) | 292.13 (391.49) | — | — | |||||||
|
| MPA (min/week) | 4.114 | .13 | 59.79 (79.63) | 60.85 (102.42) | 103.19 (190.47) | — | — | |||||||
|
| VPA (min/week) | 0.013 | .99 | 57.45 (70.42) | 58.72 (84.20) | 70.64 (134.28) | — | — | |||||||
|
| Total PA (MET min/week) | 0.973 | .62 | 1287.34 (1411.50) | 1273.57 (1277.72) | 2072.11 (2637.84) | — | — | |||||||
|
| Days of MVPA≥30 min/day | 1.244 | .54 | 2.79 (2.03) | 3.08 (2.19) | 2.98 (1.97) | — | — | |||||||
|
| Sitting (min/day) | 4.333 | .12 | 307.66 (198.22) | 239.57 (187.16) | 245.53 (187.06) | — | — | |||||||
|
| Screen time (min/day) | 3.810 | .15 | 159.36 (139.36) | 136.60 (153.07) | 131.06 (127.66) | — | — | |||||||
aWilcoxon signed-rank tests with P<.025 (planned comparisons T0 vs T1 and T0 vs T1) considered statistically significant. The Wilcoxon signed-rank test was only undertaken when the Friedman test was significant (P<.05).
bMPA: moderate-intensity physical activity.
cVPA: vigorous-intensity physical activity.
dPA: physical activity.
eMET: metabolic equivalent.
fMVPA: moderate-to-vigorous physical activity.
Differences in self-reported physical activity and sedentary behavior at baseline (T0), 4 weeks (T1), and 8 weeks (T2) according to history of eHealth app use (N=87).
| Variable | Friedman test | T0, mean (SD) | T1, mean (SD) | T2, mean (SD) | |||||||||||
|
|
|
|
| T0 vs T1 | T0 vs T2 | ||||||||||
|
| |||||||||||||||
|
| Walking (min/week) | 2.229 | 0.328 | 186.51 (225.17) | 170.23 (150.92) | 211.16 (287.61) | — | — | |||||||
|
| MPAb (min/week) | 0.043 | 0.979 | 68.37 (89.39) | 65.35 (75.29) | 99.77 (161.10) | — | — | |||||||
|
| VPAc (min/week) | 1.938 | 0.380 | 61.39 (76.67) | 80.93 (95.74) | 86.98 (137.52) | — | — | |||||||
|
| Total PAd (METe min/week) | 2.306 | 0.316 | 1408.05 (1231.73) | 1408.28 (1110.01) | 1842.88 (2428.60) | — | — | |||||||
|
| Days of MVPAf≥30 min/day | 8.122 | 0.017 | 2.65 (1.91) | 3.70 (2.08) | 3.37 (2.08) | .001 | .03 | |||||||
|
| Sitting (min/day) | 16.014 | <0.001 | 352.56 (186.57) | 241.86 (168.00) | 278.60 (177.93) | <.001 | .004 | |||||||
|
| Screen time (min/day) | 4.262 | 0.119 | 206.05 (188.28) | 128.37 (102.91) | 143.95 (142.20) | — | — | |||||||
|
| |||||||||||||||
|
| Walking (min/week) | 8.488 | 0.014 | 174.32 (297.76) | 165.45 (161.48) | 295.45 (338.15) | .32 | <.001 | |||||||
|
| MPA (min/week) | 2.764 | 0.251 | 53.86 (84.53) | 62.27 (116.16) | 82.27 (157.40) | — | — | |||||||
|
| VPA (min/week) | 1.048 | 0.592 | 64.09 (71.38) | 49.55 (64.30) | 61.82 (78.60) | — | — | |||||||
|
| Total PA (MET min/week) | 4.409 | 0.110 | 1262.52 (1451.08) | 1242.36 (1329.49) | 1880.45 (1867.42) | — | — | |||||||
|
| Days of MVPA ≥30 min/day | 1.248 | 0.536 | 2.84 (2.06) | 2.64 (1.88) | 2.95 (1.92) | — | — | |||||||
|
| Sitting (min/day) | 1.987 | 0.370 | 316.36 (215.99) | 278.64 (200.76) | 255.91 (202.66) | — | — | |||||||
|
| Screen time (min/day) | 1.822 | 0.402 | 146.36 (111.11) | 160.68 (158.49) | 146.82 (155.11) | — | — | |||||||
aWilcoxon signed-rank tests with P<.025 (planned comparisons T0 vs T1 and T0 vs T1) considered statistically significant. The Wilcoxon signed-rank test was only undertaken when the Friedman test was significant (P<.05).
bMPA: moderate-intensity physical activity.
cVPA: vigorous-intensity physical activity.
dPA: physical activity.
eMET: metabolic equivalent.
fMVPA: moderate-to-vigorous physical activity.
Differences in self-reported physical activity and sedentary behavior at baseline (T0), 4 weeks (T1), and 8 weeks (T2) according to level of household participation (N=87).
| Variable | Friedman test | T0, mean (SD) | T1, mean (SD) | T2, mean (SD) | |||||||
|
|
|
|
| T0 vs T1 | T0 vs T2 | ||||||
|
| |||||||||||
|
| Walking (min/week) | 15.282 | <0.001 | 128.07 (131.05) | 164.74 (135.44) | 251.40 (303.42) | .02 | <.001 | |||
|
| MPAb (min/week) | 0.304 | 0.859 | 58.07 (83.23) | 60.70 (87.64) | 70.70 (94.38) | — | — | |||
|
| VPAc (min/week) | 1.899 | 0.387 | 60.70 (68.27) | 59.82 (79.97) | 72.10 (81.96) | — | — | |||
|
| Total PAd (METe min/week) | 5.982 | 0.050 | 1130.00 (999.47) | 1268.54 (1074.55) | 1683.67 (1693.29) | .33 | .01 | |||
|
| Days of MVPAf≥30 min/day | 4.383 | 0.112 | 2.58 (1.94) | 3.17 (2.20) | 3.25 (2.15) | — | — | |||
|
| Sitting (min/day) | 11.223 | 0.004 | 360.88 (203.15) | 277.02 (199.61) | 280.88 (191.29) | <.001 | .002 | |||
|
| Screen time (min/day) | 3.362 | 0.186 | 183.51 (176.85) | 136.67 (137.05) | 146.67 (157.96) | — | — | |||
|
| |||||||||||
|
| Walking (min/week) | 0.241 | 0.887 | 279.67 (395.30) | 173.67 (190.25) | 258.33 (341.85) | — | — | |||
|
| MPA (min/week) | 2.960 | 0.228 | 66.67 (94.33) | 69.67 (115.47) | 129.33 (234.58) | — | — | |||
|
| VPA (min/week) | 0.526 | 0.769 | 66.67 (83.97) | 75.00 (87.40) | 78.33 (155.01) | — | — | |||
|
| Total PA (MET min/week) | 0.218 | 0.897 | 1722.90 (1779.90) | 1430.43 (1475.97) | 2200.50 (2827.74) | — | — | |||
|
| Days of MVPA ≥30 min/day | 0.587 | 0.746 | 3.07 (2.03) | 3.13 (1.74) | 3.00 (1.70) | — | — | |||
|
| Sitting (min/day) | 3.453 | 0.178 | 283.67 (191.93) | 229.00 (152.14) | 241.00 (188.14) | — | — | |||
|
| Screen time (min/day) | 2.272 | 0.321 | 161.33 (107.63) | 160.00 (129.32) | 143.00 (129.51) | — | — | |||
aWilcoxon signed-rank tests with P<.025 (planned comparisons T0 vs T1 and T0 vs T1) considered statistically significant. The Wilcoxon signed-rank test was only undertaken when the Friedman test was significant (P<.05).
bMPA: moderate-intensity physical activity.
cVPA: vigorous-intensity physical activity.
dPA: physical activity.
eMET: metabolic equivalent.
fMVPA: moderate-to-vigorous physical activity.